Intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first line treatment in advanced non-small lung cancer (NSCLC) patients: preliminary results of a prospective study

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

SKŘIČKOVÁ Jana KEILOVÁ Jana JANÁSKOVÁ Tereza KOLEK Vítězslav CHALUPA Jiří ROUBEC Jaromír TŘASOŇ Tomáš TOMÍŠKOVÁ Marcela KADLEC Bohdan ŠVECOVÁ Jiřina GRYGÁRKOVÁ Ivona KOHOUTEK Milan

Year of publication 2009
Type Article in Periodical
Magazine / Source Journal of Thoracic Oncology
MU Faculty or unit

Faculty of Medicine

Citation
Field Pneumology
Keywords Vinorelbine intravenous and oral; carboplatin; first line treatment in advanced non-small lung cancer (NSCLC) patients; preliminary results of a prospective study
Description Preliminary results are presented of a prospective trial of intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first line treatment in patients with advanced non-small lung cancer (NSCLC) patients: preliminary results of a prospective study
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info